Archive

How the Vac4covid study will collect data

Written by Christine Clark | 7 Apr 2021

Interview and article by Christine Clark. Gavin Dobson, Clinical Trials Pharmacist at MEMO Research explains the practical details of the Vac4covid study. The Vac4covid study will recruit at… read more.

EMA validates MAA for Trodelvy under accelerated review in triple-negative breast cancer – Gilead Sciences

Written by Charlie King | 6 Apr 2021

Gilead Sciences announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for Trodelvy (sacituzumab govitecan-hziy) (SG) for the treatment of adult patients with… read more.

Stem cell transplants prevent relapses of most common childhood cancer

Written by Charlie King | 6 Apr 2021

Children and young adults who receive CAR T-cell therapy for the most common childhood cancer – acute lymphoblastic leukemia – suffer remarkably fewer relapses and are far more… read more.

Studying people’s experience of covid-19 vaccination – Vac4covid

Written by Christine Clark | 6 Apr 2021

Interview and article by Christine Clark. The Vac4covid study has been designed to provide important data about the safety and effectiveness of covid-19 vaccines. IMI interviewed Mr Gavin… read more.

EMA validates MAA for relugolix for the treatment of advanced prostate cancer – Myovant Sciences

Written by Charlie King | 5 Apr 2021

Myovant Sciences announced the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for relugolix for the treatment of advanced prostate cancer. The validation of the… read more.

Is there perceived poor judgment of autistic adults?

Written by Charlie King | 5 Apr 2021

Autistic adults can be wrongly perceived as deceptive and lacking credibility, Flinders University researchers say, with this working against many caught in the legal system. Ahead of World… read more.

Pfizer-BioNTech announce positive topline results of pivotal COVID-19 vaccine study in adolescents

Written by Charlie King | 4 Apr 2021

Pfizer Inc. and BioNTech SE announced that, in a Phase III trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection,… read more.

Early sugary diet could mean memory trouble later

Written by Charlie King | 4 Apr 2021

New research shows how drinking sugary beverages early in life may lead to impaired memory in adulthood. The study, published today in Translational Psychiatry, also is the first to… read more.

European Commission grants conditional approval for Nexpovio to treat multiple myeloma – Karyopharm Therapeutics

Written by Charlie King | 3 Apr 2021

Karyopharm Therapeutics Inc. announced that the European Commission (EC) has granted conditional marketing authorization for Nexpovio (selinexor), the Company’s first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) medicine,… read more.

Gut microbiota in cesarean-born babies catches up

Written by Charlie King | 3 Apr 2021

Infants born by cesarean section have a relatively meager array of bacteria in the gut. But by the age of three to five years they are broadly in… read more.

Health Canada approves Taltz for pediatric patients with plaque psoriasis – Eli Lilly

Written by Charlie King | 2 Apr 2021

Health Canada issued a Notice of Compliance for Taltz (ixekizumab), from Eli Lilly, injection, 80 mg/mL, for the treatment of pediatric patients from six to less than 18… read more.

Study led by Hamilton scientists has found a link between eating processed meat and a higher risk of cardiovascular disease

Written by Charlie King | 2 Apr 2021

The information comes from the diets and health outcomes of 134,297 people from 21 countries spanning five continents, who were tracked by researchers for data on meat consumption… read more.

« Previous 1 … 47 48 49 50 51 … 63 Next »

Archive

Subscribe for our mailing list

Follow Us